Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. EMEA Innovative Medicine /
    2. About us

    About us

    We innovate with purpose to lead where medicine is going. Inspired by patients and the legacy of industry pioneer Dr. Paul Janssen, we continue with the vision of developing science-based innovations to change and save lives.
    About us hero .webp

    Johnson & Johnson Innovative Medicine is leading where medicine is going.

    Our diverse and innovative product portfolio spans multiple focus areas —Oncology, Immunology, Neuroscience, Pulmonary Hypertension, Communicable Diseases and Cardiopulmonary. We apply rigorous science and compassion to confidently adddress the most complex diseases of our time and take bold actions to deliver the support patients need.

    Who is Johnson & Johnson Innovative Medicine EMEA?

    We are here to transform the future of healthcare by tackling some of the most important public health issues across Europe, the Middle East and Africa. The experiences of patients and healthcare professionals around the world inform and inspire our science-based innovations, which continue to change and save lives.
    zomc-24550h-h-c-always-on-launch-video-cc-16x9-2-1.mp4
    zomc-24550h-h-c-always-on-launch-video-cc-16x9-2-1.mp4
    Picture1.jpg

    Our Credo

    Guided by the values in Our Credo, we apply high ethical standards in all areas of our business.
    View Our Credo

    Our responsibilities

    We are committed to the people we serve, We understand the needs of patients and healthcare professionals, and their experiences inform how we develop transformational medicines.

    • To patients

      Patients are our priority, and the experts by experience. We understand that high-quality treatments and services go hand-in-hand with easily available information, so that you feel empowered and in control of your healthcare.
      Read more

    • To healthcare professionals

      We invest in education programmes, materials and events, making them part of our responsibility for the medicines we develop.
      Read more

    • Sustainability

      With our resources, expertise and collaborations, we are taking action to test and champion sustainable access models to drive health forward for all in an increasingly complex world.
      Read more

    Our heritage

    As part of Johnson & Johnson, we work to understand and address the serious health problems of today and unlock the potential medicines of tomorrow.
    Read more

    Our innovation

    Johnson & Johnson Innovative Medicine has always been forward-thinking. From game-changing apps and first-in-class therapies to medical devices, we’re exploring beyond the conventional. That’s because we think being creative, ambitious and forward-focused is the best way to meet our goal of making disease a thing of the past.

    • JLABS

      JLABS is a global network of open innovation centres, that enables innovators across the healthcare spectrum to create and accelerate the delivery of lifesaving, life-enhancing health solutions to patients around the world.

      The first JLAB in Europe, JLABS @ BE in Beerse, Belgium is home to life science start-ups focused on innovations across the entire healthcare spectrum, including pharmaceuticals, medical devices, consumer and health technology.
      Read more

    • Innovation centres

      Johnson & Johnson has established Innovation Centers in the world’s top life science hubs, which are constantly working on new ideas for improving human health.

      Our EMEA Innovation Center in London is a regional hub for collaborations throughout Europe, Middle East and Africa (EMEA), with networks in innovation hotspots such as Switzerland, Scandinavia, France and Germany.
      Read more

    • Partner with us

      We’re committed to partnering to develop solutions that bring value to patients, healthcare professionals and healthcare systems across the region.
      Know more

    • Contact us

      J&J Innovative Medicine EMEA operates in multiple countries
      Know more

    CP-459038
    September 2024